InformationDS-1001b (DS 1001) DS-1001b is an oral selective inhibitor of mutant IDH1 R132X with potential antineoplastic activity and is designed to penetrate the blood-brain barrier.TargetsIDH1 R132XIn vitroDS-1001b impairs the proliferation of IDH1 mutant chondrosarcoma cell lines and decreases 2-HG levels.In vivoContinuous administration of DS-1001b impairs tumor growth in xenograft mice.Cell Research(from reference)Cell lines:JJ012,L835 cell lines Concentrations:0-10µM Incubation Time:72 h.
Specifications and Purity: ≥98%
Molecular Formula: C29H29Cl3FN3O4
Molecular Weight: 608.92
PubChem CID: 139600317
Isomeric SMILES: CC1=CN(C2=CC=CC(=C12)/C=C/C(=O)O)C(=O)C3=C(ON=C3C4=C(C=C(C=C4Cl)Cl)Cl)C(C)(C)F.CC(C)(C)N
- UPC:
- 41106102
- Condition:
- New
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- D414241-100mg
- CAS:
- 1898207-64-1
- Product Size:
- 100mg
akash.verma@cenmed.com
(732) 447-1115





